13G PHAT 10312024

Company

Phathom Pharmaceuticals, Inc.

Filed

November 4, 2024

Accession Number

0000053417-24-000085

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →